Clinical Trial Update: The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis. [Phase 3]

View source ↗

Summary

Phase 3 INVIGORATE trial for seasonal allergic conjunctivitis has completed and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Conjunctivitis

Drugs mentioned

• Investigational therapy (Aldeyra Therapeutics)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2024-11-20